MCL Clinical Trials
1230 trials from ClinicalTrials.gov. Recruiting trials shown first.
Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's Lymphoma
COMPLETEDNCT00897923·Mayo Clinic·17 enrolled
radionuclide imagingindium In 111-labeled autologous peripheral blood mononuclear cellsindium In 111-labeled autologous polymorphonuclear leukocytes
Bendamustine Plus Rituximab Versus Fludarabine Plus Rituximab
COMPLETEDNCT01456351·PHASE3·University of Giessen·230 enrolled
Bendamustine plus RituximabFludarabine 25 mg/m² d 1-3 + Rituximab 375 mg/m² d 1 q4w
Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies
COMPLETEDNCT00072514·PHASE2·Fred Hutchinson Cancer Center·55 enrolled
gemcitabine hydrochloridecarboplatindexamethasonerituximab
Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer
COMPLETEDNCT00248430·PHASE1 / PHASE2·Fred Hutchinson Cancer Center·20 enrolled
aldesleukintherapeutic allogeneic lymphocytesmelphalanbone marrow ablation with stem cell supportperipheral blood stem cell transplantation
Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer
COMPLETEDNCT00070382·PHASE3·Jonsson Comprehensive Cancer Center·14 enrolled
darbepoetin alfaepoetin alfa
Bortezomib and Fludarabine With or Without Rituximab in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
COMPLETEDNCT00068315·PHASE1·National Cancer Institute (NCI)·18 enrolled
bortezomibfludarabine phosphaterituximab
Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies
COMPLETEDNCT00068523·NA·Case Comprehensive Cancer Center·10 enrolled
anti-thymocyte globulincyclophosphamidecyclosporinefludarabine phosphatemethylprednisolone+3 more
VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
COMPLETEDNCT00063713·PHASE2·Millennium Pharmaceuticals, Inc.·152 enrolled
VELCADE TM (bortezomib) for Injection
Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation
COMPLETEDNCT00064311·PHASE1 / PHASE2·National Institutes of Health Clinical Center (CC)
ravuconazole
Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation
COMPLETEDNCT00089037·PHASE1 / PHASE2·Fred Hutchinson Cancer Center
methotrexatesirolimustacrolimus
Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Cancer
COMPLETEDNCT00062140·PHASE1·Fred Hutchinson Cancer Center
cyclophosphamideallogeneic bone marrow transplantationperipheral blood stem cell transplantationradiation therapy
Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell Lymphoma
COMPLETEDNCT00058227·PHASE1·National Cancer Institute (NCI)·37 enrolled
alvocidibfludarabine phosphaterituximabpharmacological study
BCX-1777 in Treating Patients With Refractory Cancer
COMPLETEDNCT00073944·PHASE1·BioCryst Pharmaceuticals
forodesine hydrochloride
Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer
COMPLETEDNCT00060372·PHASE1·National Cancer Institute (NCI)·21 enrolled
ipilimumabtherapeutic allogeneic lymphocytes
Bryostatin 1 Plus Vincristine in Treating Patients With Progressive or Relapsed Non-Hodgkin's Lymphoma After Bone Marrow or Stem Cell Transplantation
COMPLETEDNCT00058305·PHASE2·National Cancer Institute (NCI)·28 enrolled
bryostatin 1vincristine sulfatelaboratory biomarker analysis
Oblimersen and Gemcitabine in Treating Patients With Advanced Solid Tumor or Lymphoma
TERMINATEDNCT00060112·PHASE1·National Cancer Institute (NCI)·15 enrolled
oblimersen sodiumgemcitabine hydrochloridepharmacological studylaboratory biomarker analysis
Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
COMPLETEDNCT00062296·PHASE2·Fox Chase Cancer Center·5 enrolled
rituximabepirubicin hydrochloride
Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation
COMPLETEDNCT00060021·NA·National Cancer Institute (NCI)
acupuncture therapymanagement of therapy complicationspain therapy
Ixabepilone in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
COMPLETEDNCT00058019·PHASE2·National Cancer Institute (NCI)·51 enrolled
ixabepilone
Rituximab and Cladribine in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma
COMPLETEDNCT00053027·PHASE2·Alliance for Clinical Trials in Oncology·30 enrolled
rituximabcladribine
Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's Lymphoma
COMPLETEDNCT00115193·PHASE2·Amgen·77 enrolled
pegfilgrastimpegfilgrastim
Bortezomib in Treating Patients With Advanced Cancer and Kidney Dysfunction
COMPLETEDNCT00054483·PHASE1·National Cancer Institute (NCI)·69 enrolled
bortezomiblaboratory biomarker analysispharmacological study
Oblimersen Sodium and Rituximab in Treating Patients With Recurrent B-cell Non-Hodgkin Lymphoma
COMPLETEDNCT00054639·PHASE2·National Cancer Institute (NCI)·48 enrolled
oblimersen sodiumrituximablaboratory biomarker analysis
Long-Term Effects of Iodine I Tositumomab and Autologous Bone Marrow or Stem Cell Transplantation in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
COMPLETEDNCT00098566·Fred Hutchinson Cancer Center·36 enrolled
Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
COMPLETEDNCT00053053·PHASE3·Radiation Therapy Oncology Group·472 enrolled
JuvenNon-Juven Supplement
Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer
COMPLETEDNCT00265837·PHASE3·Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins·72 enrolled
graft versus host disease prophylaxis/therapyallogeneic bone marrow transplantationin vitro-treated bone marrow transplantation
Bortezomib in Treating Patients With Mantle Cell Lymphoma
COMPLETEDNCT00030875·PHASE2·NCIC Clinical Trials Group·30 enrolled
bortezomib
Pilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic Malignancies
TERMINATEDNCT00514722·NA·University of California, San Francisco·4 enrolled
umbilical cord stem cells
Ixabepilone in Treating Patients With Relapsed or Refractory Lymphoproliferative Disorders
COMPLETEDNCT00052572·PHASE2·Memorial Sloan Kettering Cancer Center·35 enrolled
ixabepilone
Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or Lymphoma
COMPLETEDNCT00049712·PHASE1·University of Wisconsin, Madison
etaracizumab